Safety and Efficacy Study of Lotus Valve for Transcatheter Aortic Valve Replacement
A trial with no phase registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 1425 participants.
Also called NCT02202434
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 1,425 participants
- Sponsor
- Registry
-
NCT02202434
-
- Other papers using this trial's data
- Clinical Implications of Physical Function and Resilience in Patients Undergoing Transcatheter Aortic Valve Replacement
- Effect of Mechanically Expanded vs Self-Expanding Transcatheter Aortic Valve Replacement on Mortality and Major Adverse Clinical Events in High-Risk Patients With Aortic Stenosis: The REPRISE III Randomized Clinical Trial
- Hemodynamic and Echocardiographic Comparison of the Lotus and CoreValve Transcatheter Aortic Valves in Patients With High and Extreme Surgical Risk: An Analysis From the REPRISE III Randomized Controlled Trial
- Long-term Outcomes of Transcatheter Aortic Valve Replacement With the Lotus Valve vs CoreValve/EvolutR: A Secondary Analysis of the REPRISE III Randomized Clinical Trial
- Pacemaker Implantation and Dependency After Transcatheter Aortic Valve Replacement in the REPRISE III Trial
- Two-Year Outcomes After Transcatheter Aortic Valve Replacement With Mechanical vs Self-expanding Valves: The REPRISE III Randomized Clinical Trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Australia, Canada, France, Germany, Netherlands
- Registry status
- Terminated
Technical summary
Registry record NCT02202434. Randomized; no masking; primary purpose treatment. Start 2014-09-22 (actual); primary completion 2017-03-08 (actual). Results posted on 2019-07-30.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Safety and Efficacy Study of Lotus Valve for Transcatheter Aortic Valve Replacement
- Acronym
- REPRISE III
- Condition
- Aortic Stenosis
- Intervention (Device)
- Lotus Valve System
- Intervention (Device)
- CoreValve/Evolut R Transcatheter Aortic Valve Replacement System
- Intervention (Device)
- LOTUS Edge Valve System
- Lead sponsor
- Boston Scientific Corporation
Record details
- Record id
cardio:ct-nct02202434- Content hash
490908958bce11f3de022b69ae591c70e1443f6455d9eaa378601a37e87b750d